Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jan 28;352:i262. doi: 10.1136/bmj.i262

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/.

PMC Copyright notice

graphic file with name raap028130.f1_default.jpg — Fig 1 Hazard ratios (95% CI) for squamous cell cancer among 46 409 biologics-naive patients with rheumatoid arthritis (RA) compared with 379 666 matched general population comparators and among 12 558 tumour necrosis factor (TNF) inhibitor treated patients with RA compared with general population comparators. Hazard ratios (95% CI) for basal cell cancer among 43 675 biologics-naive patients with RA compared with 364 584 matched general population comparators and among 8827 TNF inhibitor treated patients with RA compared with general population comparators. Hazard ratios for TNF inhibitor treated patients versus general population comparators are not discussed elsewhere in the paper but are shown here for comparison